Apple Pre-earnings Analysis Apple just tapped the $4 trillion market cap for the first time in history, making them the second largest company by market cap after Nvidia. That puts pressure on them to perform on earnings, otherwise they’re rising losing investor confidence from these highs and trigger profit taking. The biggest focus on earnings will be iPhone sales. The new iPhone 17 was supposed to spark a big upgrade cycle, with most analysts expecting about a 10% revenue growth from phone sales alone. This is a key metric to watch because it will measure how this model is doing compared to the iPhone 16. Counterpoint Research shows that iPhone sales during the first 10 days after launch in U.S....
Google Pre-earnings Analysis Not long ago, Google was lagging far behind the market, but optimism around their core advertising business, cloud & AI momentum, and regulatory relief has sparked a monster rally, leaving the stock up 42% YTD at the time of this writing. But as earnings approach and as the stock sits at record highs, the question is whether or not they’ll post a strong enough report to maintain these highs, or if their earnings are already priced in. Looking at the numbers, Google is expected to post revenue of $99.94 and earnings per shares of $2.26. The company has a long history of meeting and exceeding expectations, so there’s a good probability they’ll do so this time again....
Merck & Company Pre-earnings Analysis As market valuations get stretched to record highs, investors are searching for “undercover” opportunities to take on. The pharmaceutical space is of those “undercover” opportunities that has lagged far behind the market rally, potentially being a good place for investors with a longer time horizon to park capital. Before getting into the upside, let’s talk about why pharmaceuticals are trading far behind the market:The most prominent reason pharmaceutical stocks aren’t catching rhythm is because of the ongoing regulatory and pricing pressure from the current administration. In the U.S., there’s a strong policy rhetoric around forcing drug price reductions, creating margin risk for investors. And beyond pricing, tariffs on pharmaceutical imports is also a threat. For...
Chipotle Pre-earnings Analysis Chipotle stock has been beaten down over the past twelve months as the company suffers from slowing growth, especially in same store sales in North America. From the years 2022-2024, Chipotle managed to report consistent revenue growth around 14%, but Q1 and Q2 of 2025 slowed to just 6.4% and 3.04% growth, leading investors to scale back on their positions and leaving the stock in “free fall,” especially after the last report, when net income also dipped, falling 4.3% YoY. Although Chipotle remains a dominant force in the fast casual dining segment, its near term outlook is complicated by a maturing U.S. market. After years of price hikes, many consumers are turning to home cooked meals or...
Taiwan Semiconductor Manufacturing Company A.K.A TSMC ($TSM) Pre-earnings Analysis All eyes are on the semiconductor industry this week as TSMC, the world’s most advanced chipmaker, gets ready to report quarterly earnings. As the key supplier behind Nvidia’s and AMD’s cutting edge chips, TSMC’s results often set the tone for the entire tech sector, and could offer insight into where AI-driven demand is headed next. In case you don’t know, TSMC produces roughly 60% of the world’s total semiconductor chips and over 90% of global advanced chips. Yes, companies like Apple, Nvidia, AMD, and Qualcomm design their own chips, but it’s TSMC that actually manufactures them. That makes TSMC’s earnings crucial, as they serve as a real time reflection of global...
